WFA Asset Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$102K Sell
1,620
-44
-3% -$3.02K 0.06% 72
2025
Q2
$98.3K Sell
1,664
-286
-15% -$18.8K 0.06% 73
2025
Q1
$156K Buy
1,950
+627
+47% +$37.5K 0.08% 64
2024
Q4
$59.4K Sell
1,323
-297
-18% -$16.7K 0.03% 103
2024
Q3
$102K Sell
1,620
-44
-3% -$2.57K 0.06% 72
2024
Q2
$98.3K Sell
1,664
-286
-15% -$17.9K 0.06% 73
2024
Q1
$156K Buy
1,950
+415
+27% +$31.7K 0.08% 64
2023
Q4
$121K Sell
1,535
-1,214
-44% -$86.4K 0.07% 59
2023
Q3
$192K Sell
2,749
-96
-3% -$6.8K 0.11% 52
2023
Q2
$197K Buy
2,845
+23
+0.8% +$1.64K 0.12% 53
2023
Q1
$210K Sell
2,822
-369
-12% -$30.9K 0.13% 49
2022
Q4
$297K Buy
3,191
+18
+0.6% +$1.74K 0.2% 41
2022
Q3
$303K Buy
3,173
+18
+0.6% +$1.78K 0.22% 37
2022
Q2
$292K Buy
3,155
+17
+0.5% +$1.66K 0.2% 36
2022
Q1
$318K Buy
3,138
+265
+9% +$27.8K 0.21% 35
2021
Q4
$296K Buy
+2,873
New +$265K 0.19% 35

Other funds holding CVS

WFA Asset Management's CVS Position: Q3 2025 in Review

WFA Asset Management reduced its CVS Health (CVS) stake by 2.6% in Q3 2025, selling an estimated $3.02K and leaving 1,620 shares worth $102K. The position accounts for 0.06% of the portfolio, ranked #72.

WFA Asset Management first reported a position in CVS in Q4 2021 and has held it in 16 quarters since. The position peaked at $318K in Q1 2022. 1,834 funds tracked by Wall St. Rank hold CVS as of Q3 2025.

  • WFA Asset Management held 1,620 shares of CVS Health worth $102K as of Q3 2025.
  • WFA Asset Management sold 44 CVS Health shares in Q3 2025, an estimated $3.02K.
  • CVS Health made up 0.06% of WFA Asset Management's portfolio in Q3 2025, its #72 holding.
  • WFA Asset Management first reported a position in CVS Health in Q4 2021 and has held it in 16 quarters since.
  • WFA Asset Management's CVS Health position peaked at $318K in Q1 2022.
  • 1,834 funds tracked by Wall St. Rank held CVS Health as of Q3 2025.

Based on WFA Asset Management's 13F filing for Q3 2025, filed 30 Oct 2025.